Analyst Ratings for Karyopharm Therapeutics (KPTI) [Buys]

KPTI Rating Summary

KPTI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KPTI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $17.33 (+198.9%) * Over Last 12-Mos
Rating Score: 6.9 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/2/2020 Morgan Stanley
» Updated 11/3/2020
David Lebowitz New Coverage Overweight
(N/A)
32.00
(31.00)
18.94
(5.80)
-69.38% Details
3/4/2020 Barclays
» Updated 2/12/2021
Peter Lawson New Coverage Overweight
(N/A)
22.00
(26.00)
27.72
(5.80)
-79.08% Details
Like KPTI Ratings? Also take a look at REPL

KPTI Ratings News